Search Results

You are looking at 1 - 10 of 25 items for :

  • Carbimazole x
  • All content x
Clear All
Open access

Ehtasham Ahmad, Kashif Hafeez, Muhammad Fahad Arshad, Jimboy Isuga, and Apostolos Vrettos

could be suggestive of early Graves’ disease. Treatment Based on the above results, there was little doubt that patient had underlying Graves’ disease now and was commenced on Carbimazole 30 mg once a day in 2017. Outcome and follow

Open access

Anastasia Dimakopoulou, Karunakaran Vithian, David Gannon, and Allan Harkness

with subclinical hyperthyroidism. Nine months later, biochemical hyperthyroidism developed with a thyroid-stimulating hormone (TSH) of <0.01 mU/l, a free thyroxine (T 4 ) of 42.2 pmol/l and free triiodothyronine (T 3 ) of 18 pmol/l. Carbimazole was

Open access

J K Witczak, N Ubaysekara, R Ravindran, S Rice, Z Yousef, and L D Premawardhana

initially given carbimazole when Graves’ disease was first diagnosed but had discontinued treatment for unknown reasons after only a few weeks and presented again a few months later. Clinically he appeared thyrotoxic with a regular pulse of 96/min, BP 111

Open access

Hui Yi Ng, Divya Namboodiri, Diana Learoyd, Andrew Davidson, Bernard Champion, and Veronica Preda

chiasm. (B) 3-month post-op: removal of pituitary macroadenoma, residual pituitary gland posteriorly. Treatment He was commenced on carbimazole 15 mg BD and propranolol 40 mg BD (metoprolol ceased). At 1 month, he was clinically and

Open access

T Min, S Benjamin, and L Cozma

). Treatment He remained in the ITU. Treatment with i.v. steroid and 20 mg OD carbimazole was initiated. Anticoagulation with low-molecular-weight heparin (1.5 mg/kg per day enoxaparin) was continued. Outcome and follow-up The patient made a

Open access

Arshiya Tabasum, Ishrat Khan, Peter Taylor, Gautam Das, and Onyebuchi E Okosieme

levels were consistent with T3 toxicosis: TSH 0.04U/L, FT3 9.56mol/L, and FT4 15.5pmol/L. At this point, repeat TRAb and TPOAb measurements were positive: 7.6IU/L and 67.9IU/mL, respectively ( Table 1 ). She was commenced on carbimazole initially and

Open access

Colin L Knight, Shamil D Cooray, Jaideep Kulkarni, Michael Borschmann, and Mark Kotowicz

. He was commenced on carbimazole 10 mg three times daily orally and propanolol 40 mg twice daily orally ( Fig. 1 ). One month later, he was transferred from a rural hospital to the same regional tertiary hospital with a temperature of 39.1 degrees

Open access

Carolina Shalini Singarayar, Foo Siew Hui, Nicholas Cheong, and Goay Swee En

’ disease and was commenced on carbimazole and propanolol. Free thyroxine (FT4) level was 75.5 pmol/L (normal range 11.8–23.2 pmol/L) and thyrotropin (TSH) level was <0.01 mU/L (normal range 0.35–5.50 mU/L). Echocardiography revealed an enlarged right

Open access

Maria Tomkins, Roxana Maria Tudor, Diarmuid Smith, and Amar Agha

Graves’ disease with homogenous isotope activity ( Fig. 1 ). She had no features of thyroid eye disease or extra-thyroidal manifestations. Initially, she was treated with carbimazole which she self-discontinued once her symptoms had resolved. She was

Open access

Kingsley Okolie, Daniel Chen, Raf Ghabrial, and Robert Schmidli

<60 06/2016 <0.02 6.8 19 0.9 <20 <28 11/2016 0.03 5.5 15 0.9 <20 <28 12/2016 0.06 5.4 16 Carbimazole started  01/2017 0.56 4.6 15 0.9  04/2017 2.9 5.0 15 0